ZA200704739B - Substituted cyclopentanes or cyclopentanones as therapeutic agents - Google Patents

Substituted cyclopentanes or cyclopentanones as therapeutic agents

Info

Publication number
ZA200704739B
ZA200704739B ZA200704739A ZA200704739A ZA200704739B ZA 200704739 B ZA200704739 B ZA 200704739B ZA 200704739 A ZA200704739 A ZA 200704739A ZA 200704739 A ZA200704739 A ZA 200704739A ZA 200704739 B ZA200704739 B ZA 200704739B
Authority
ZA
South Africa
Prior art keywords
cyclopentanones
therapeutic agents
substituted cyclopentanes
cyclopentanes
substituted
Prior art date
Application number
ZA200704739A
Other languages
English (en)
Inventor
David W Old
Todd S Gac
Vinh X Ngo
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of ZA200704739B publication Critical patent/ZA200704739B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/72Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings and other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/74Unsaturated compounds containing —CHO groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/90Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734Ethers
    • C07C69/736Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA200704739A 2005-01-14 2007-06-18 Substituted cyclopentanes or cyclopentanones as therapeutic agents ZA200704739B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64406905P 2005-01-14 2005-01-14

Publications (1)

Publication Number Publication Date
ZA200704739B true ZA200704739B (en) 2009-10-28

Family

ID=36678136

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200704739A ZA200704739B (en) 2005-01-14 2007-06-18 Substituted cyclopentanes or cyclopentanones as therapeutic agents

Country Status (19)

Country Link
US (1) US7635716B2 (fr)
EP (1) EP1846354B1 (fr)
JP (1) JP5060311B2 (fr)
KR (1) KR101227808B1 (fr)
CN (1) CN101102989B (fr)
AR (1) AR052876A1 (fr)
AT (1) ATE465986T1 (fr)
AU (1) AU2006205029B2 (fr)
BR (1) BRPI0605926A2 (fr)
CA (1) CA2593661A1 (fr)
DE (1) DE602006013945D1 (fr)
DK (1) DK1846354T3 (fr)
ES (1) ES2343430T3 (fr)
IL (1) IL184025A (fr)
MX (1) MX2007008188A (fr)
NZ (1) NZ555945A (fr)
TW (1) TWI379696B (fr)
WO (1) WO2006076370A2 (fr)
ZA (1) ZA200704739B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7799336B2 (en) 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
WO2007005176A1 (fr) 2005-06-29 2007-01-11 Allergan, Inc. Pyrrolidinones dans le traitement de glaucomes et d'hypertension oculaire
WO2007149829A2 (fr) * 2006-06-20 2007-12-27 Allergan, Inc. Composés thérapeutiques
US7605178B2 (en) * 2006-07-10 2009-10-20 Allergan, Inc. Therapeutic compounds
US20080015219A1 (en) * 2006-07-11 2008-01-17 Allergan, Inc. Therapeutic compounds
US7507817B2 (en) * 2006-11-17 2009-03-24 Allergan, Inc. Prostaglandin prodrugs
CA2675632A1 (fr) * 2007-01-22 2008-07-31 Allergan, Inc. Arylcyclopentenes substitues comme agents therapeutiques
JP5453254B2 (ja) * 2007-07-03 2014-03-26 アラーガン インコーポレイテッド 眼圧降下用の治療用置換シクロペンタン類
JP5566902B2 (ja) * 2007-11-29 2014-08-06 アラーガン インコーポレイテッド プロスタグランジン活性を有する置換シクロペンタン類
BRPI0911543A2 (pt) * 2008-04-24 2015-10-13 Allergan Inc arilciclopentenos substituídos como agentes terapêuticos
PT3062775T (pt) 2013-10-31 2018-03-06 Allergan Inc Implantes intraoculares contendo prostamida e métodos para a sua utilização
TW201613864A (en) 2014-02-20 2016-04-16 Takeda Pharmaceutical Novel compounds
WO2015175544A1 (fr) 2014-05-12 2015-11-19 Allergan, Inc. Esters d'alkyle ammonium quaternaire de dérivés prostanoïdes utilisés comme promédicaments stables

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3980700A (en) 1971-10-07 1976-09-14 G. D. Searle & Co. Prostaglandin intermediates and optically active isomers thereof
SE436037B (sv) * 1976-04-30 1984-11-05 Roussel Uclaf Sett att framstella nya 11-desoxi-prostaglandin-f?712-derivat
US5510383A (en) * 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
ES2303341T3 (es) 1996-12-20 2008-08-01 Pfizer Inc. Prevencion y tratamiento de trastorno del esqueleto con agonistas de la prostaglandina e2 selectivos del subtipo de receptor ep2.
AU7349298A (en) 1997-06-23 1999-01-04 Pfizer Inc. Prostaglandin agonists
US6437146B1 (en) 1998-09-25 2002-08-20 Fujisawa Pharmaceutical Co., Ltd. Oxazole compounds as prostaglandin e2 agonists or antagonists
IL139941A0 (en) 1999-12-02 2002-02-10 Pfizer Prod Inc Use of prostaglandin agonists to treat erectile dysfunction or impotence
US6291522B1 (en) * 2000-09-27 2001-09-18 Allergan Sales, Inc. Cyclopentane heptan(ENE)oic acid, 2-thiocarbamoyloxy and 2-carbamoyloxy compounds as therapeutic agents
NZ532519A (en) 2001-11-05 2006-11-30 Allergan Inc Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists
AU2003211574A1 (en) 2002-03-05 2003-09-16 Ono Pharmaceutical Co., Ltd. 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
US20070167403A1 (en) 2003-04-03 2007-07-19 Yoshifumi Takenobu Remedy for spinal canal stenosis
US7323591B2 (en) * 2006-01-10 2008-01-29 Allergan, Inc. Substituted cyclopentanes or cyclopentanones as therapeutic agents
WO2007149829A2 (fr) * 2006-06-20 2007-12-27 Allergan, Inc. Composés thérapeutiques

Also Published As

Publication number Publication date
ATE465986T1 (de) 2010-05-15
JP5060311B2 (ja) 2012-10-31
CA2593661A1 (fr) 2006-07-20
WO2006076370A2 (fr) 2006-07-20
NZ555945A (en) 2011-01-28
DK1846354T3 (da) 2010-08-16
US7635716B2 (en) 2009-12-22
EP1846354A2 (fr) 2007-10-24
KR20070094919A (ko) 2007-09-27
IL184025A0 (en) 2008-12-29
TWI379696B (en) 2012-12-21
US20080058414A1 (en) 2008-03-06
BRPI0605926A2 (pt) 2009-05-26
AU2006205029B2 (en) 2012-09-06
HK1114601A1 (en) 2008-11-07
WO2006076370B1 (fr) 2007-02-22
ES2343430T3 (es) 2010-07-30
WO2006076370A3 (fr) 2007-01-11
EP1846354B1 (fr) 2010-04-28
CN101102989B (zh) 2011-11-16
MX2007008188A (es) 2007-08-07
AR052876A1 (es) 2007-04-11
TW200714312A (en) 2007-04-16
KR101227808B1 (ko) 2013-01-30
CN101102989A (zh) 2008-01-09
DE602006013945D1 (de) 2010-06-10
IL184025A (en) 2012-09-24
JP2008526970A (ja) 2008-07-24
AU2006205029A1 (en) 2006-07-20

Similar Documents

Publication Publication Date Title
ZA200704739B (en) Substituted cyclopentanes or cyclopentanones as therapeutic agents
GB0518390D0 (en) Therapeutic compounds
GB0518237D0 (en) Therapeutic compounds
GB0506147D0 (en) Therapeutic agents
GB0509326D0 (en) Therapeutic compounds
GB0509573D0 (en) Therapeutic compounds
GB0518361D0 (en) Therapeutic compounds
GB0516091D0 (en) Therapeutic agent
GB0519797D0 (en) Therapeutic agents
GB0522881D0 (en) Therapeutic compounds
GB0505725D0 (en) Therapeutic agents
GB0505437D0 (en) Therapeutic agents
GB0509405D0 (en) Therapeutic compounds
GB0518819D0 (en) Therapeutic agents
GB0519350D0 (en) Therapeutic agents
GB0518817D0 (en) Therapeutic agents
GB0513747D0 (en) Therapeutic compounds
GB0516661D0 (en) Therapeutic agents
GB0514738D0 (en) Therapeutic agents
GB0522130D0 (en) Therapeutic compounds
GB0507003D0 (en) Therapeutic
GB0526107D0 (en) Therapeutic Compounds
GB0518235D0 (en) Therapeutic compounds
GB0518720D0 (en) Therapeutic combination
GB0523998D0 (en) Therapeutic agents